Woman shares why she stopped using weight loss drug, Mounjaro, even after it helped her lose 31 kilos

The world’s obsession with weight loss and fat reduction, especially for women, is a trend that comes up to the surface on-again-off-again, but never really goes away. Whether with the help of cosmetic surgery, or by injecting fat loss injections, or even swallowing similar kinds of pills – weight management is the aim that’s never not chased.
While several people have come forward to share their life-changing experiences with weight loss pills and injections like Ozempic, their glorious perks must come with concerning cons as well.
One woman has come forward and cautioned against the medication after experiencing numerous severe side effects during her weight loss journey.

Ellie Marie, hailing from the UK, took to social media to recount her experience after using Mounjaro for six months and losing nearly five stone.
She stated: "Reasons why I had to stop Mounjaro after losing 31kg."

Ellie then shared an image listing all the health issues she encountered from the drug. She disclosed that she was experiencing rapid hair loss, along with severe heartburn, which required her to take daily medication for relief. Additionally, she faced potential gallstones, stomach ulcers, and persistent abdominal pain.
Ellie also noted that her appetite suppression ceased, leaving her feeling dizzy, nauseated, and dehydrated. After enduring the side effects for six months, she chose to discontinue the injections. As for those who claim weight loss injections are 'easy,’ Ellie emphasized it was one of the toughest decisions she had made. "People think it's easy, hardest thing I've chosen to do," she wrote in her post.

The video shared on her TikTok account @ellie.mariex quickly gained traction, amassing over 64k views, The Sun reported. Viewers swiftly took to the comments, with many reporting similar problems after beginning the injections. One commenter shared: "I stopped three months in. The nausea and dizziness were debilitating. Hope you’re feeling better now."
Another remarked: “I'm experiencing a significant amount of hair loss; I usually lose so little daily, but now I'm losing so much that I’m checking for bald spots." "Me too, lost over half of my hair, now need my gallbladder removed," wrote a third individual. Meanwhile, a fourth person stated: "I tried it for 9 weeks and felt terrible the entire time." "Exactly, same here,” agreed another. Someone else added: “Just stopped today, threw the pen away, life’s too short."

Approved by the US Food and Drug Administration for type 2 diabetes and packaged as an injection, Mounjaro (tirzepatide) has already sparked discussions over its effectiveness in managing weight, with some claiming it is superior to Ozempic, the popular weight loss drug. Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight management and is administered via subcutaneous injections (under the skin).

In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.

Mounjaro is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes.

Last month, Amy Schumer, the well-known American comedian, actor, writer, producer, and director, took to social media platform to share her feedback after using Mounjaro. She posted a video on Instagram, saying, “Mounjaro’s been great!”

Schumer opened up about undergoing hormone replacement therapy for perimenopause as well as using weight-loss medication. The 43-year-old artist also shared that she had previously tried to lose weight with Wegovy three years ago, but experienced unpleasant symptoms, recalling, “I was like puking, I couldn’t handle it. I don’t know if they’ve changed the formula, whatever." She also noted that she was having "a really good experience" taking a new weight-loss drug.

Approximately half a million people in the UK use weight loss medications, and this number is anticipated to double in the coming year. Mounjaro functions by suppressing appetite, helping individuals feel full for a longer duration. The injections are approved for individuals with type 2 diabetes and for those who are clinically obese (with a Body Mass Index of 30 or higher). A single injection is given each week, but the treatment length varies based on an individual’s weight.
The medications can be legally prescribed by licensed practitioners, including doctors, nurses, or independent prescribers from pharmacies.


While Mounjaro improves blood sugar levels, which helps lower the risk of diabetes-related complications, such as nerve damage, kidney disease, and vision loss over time, and also promotes substantial weight loss, one must keep in mind the side effects of the drug.
The most common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain.
One must talk to their healthcare provider about any side effects that seem to bother them and do not go away.